Viewing Study NCT07239102


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-01-27 @ 4:44 AM
Study NCT ID: NCT07239102
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2025-11-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Sponsor: Beijing Tiantan Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HX-B-2025058
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators